Company: DAWN
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001140361-25-013462
Chunk: 15

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 15
---
 “Documents & charters” in the “Corporate Governance” section. Members serve on these committees until their resignations or until otherwise determined by our board of directors. Audit Committee Our audit committee is composed of Scott Garland, Michael Gladstone and Saira Ramasastry. Following the Annual Meeting, our audit committee will be composed of Habib Dable, Scott Garland and Saira Ramasastry. Ms. Ramasastry is the chair of our audit committee. The members of our audit committee meet the independence requirements under Nasdaq and SEC rules and regulations. Each member of our audit committee is financially literate. In addition, our board of directors has determined that Ms. Ramasastry is an “audit committee financial expert” as that term is defined in Item 407(d)(5)(ii) of Regulation S-K promulgated under the Securities Act. This designation does not impose any duties, obligations or liabilities that are greater than those generally imposed on other members of our audit committee and our board of directors. Our audit committee is responsible for, among other things:

| • | selecting and hiring our independent registered public accounting firm; |

| • | the qualifications, independence and performance of our independent auditors; |

| • | the preparation of the audit committee report to be included in our annual proxy statement; |

| • | our compliance with legal and regulatory requirements; |

| • | our accounting and financial reporting processes, including our financial statement audits and the integrity of our consolidated financial statements; |

| • | our controls and procedures for mitigating cybersecurity and other information technology risks, including our plans to respond to data breaches; and |

| • | reviewing and approving related-person transactions. |

13

TABLE OF CONTENTS

Compensation Committee Our compensation committee is composed of Natalie Holles, William Grossman and Garry Nicholson. Ms. Holles is the chair of our compensation committee. The members of our compensation committee meet the independence requirements under Nasdaq and SEC rules and regulations. Each member of this committee is also a “non-employee director” within the meaning of Rule 16b-3 under the Exchange Act. Our compensation committee is responsible for, among other things:

| • | evaluating, recommending, approving and reviewing executive officer compensation arrangements, plans, policies and programs; |

| • | evaluating and recommending non-employee director compensation arrangements for determination by our board of directors; |

| • | the preparation of the compensation committee report to be included in our annual proxy statement; |

| • | administering our cash-based and equity